T&L Co., Ltd. (KOSDAQ:340570)

South Korea flag South Korea · Delayed Price · Currency is KRW
47,700
-1,250 (-2.55%)
At close: Oct 10, 2025
-2.55%
Market Cap385.03B
Revenue (ttm)185.32B
Net Income (ttm)45.67B
Shares Out8.07M
EPS (ttm)5,658.37
PE Ratio8.43
Forward PE7.50
Dividend750.00 (1.53%)
Ex-Dividend DateDec 27, 2024
Volume51,802
Average Volume36,645
Open48,100
Previous Close48,950
Day's Range47,200 - 48,650
52-Week Range47,200 - 85,600
Beta0.09
RSI29.53
Earnings DateNov 14, 2025

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1998
Employees 242
Stock Exchange KOSDAQ
Ticker Symbol 340570
Full Company Profile

Financial Performance

In 2024, T&L Co., Ltd.'s revenue was 174.89 billion, an increase of 51.47% compared to the previous year's 115.46 billion. Earnings were 46.41 billion, an increase of 69.13%.

Financial Statements

News

There is no news available yet.